Oxybutynin Chloride Tablet
Product Images NDC 69315-182

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Oxybutynin Chloride (NDC 69315-182). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Leading Pharma, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Container5mg1000cc (5mg1000ct)

Oxybutynin Chloride Tablets, USP 5 mg oral tablets packaging label. The label shows the product in a dose of 5 mg, with a count of 1000 tablets. It is designated as Rx only and manufactured by Leading Pharma, LLC. The label includes basic dosage instructions and storage conditions, with the product name prominently displayed alongside images of two tablets.*

FDA Label Image

Container5mg100cc (5mg100ct)

Oxybutynin Chloride Tablets, USP 5 mg in a bottle label for oral tablets. The label shows a 100 tablet count, Rx only. Labeler is Leading Pharma, LLC. The label includes dosage instructions, storage conditions, and barcodes. Tablet images of a round, white tablet are visible on the label.*

FDA Label Image

Container5mg500cc (5mg500ct)

Label for Oxybutynin Chloride Tablets, USP 5 mg by Leading Pharma, LLC. The label states the product is for prescription use only and contains 500 oral tablets. It includes dosage instructions, storage conditions, and manufacturer contact information. The label also features images of the round, white tablets with imprint 'LP 182.'*

FDA Label Image

Chem Structure (Chemstructure)

Chemical structure diagram showing oxybutynin chloride and its enantiomer, depicting the molecular arrangement of the active ingredient in the medication.*

FDA Label Image

Figure1 (Figure1)

A pharmacokinetic line graph showing mean plasma R-Oxybutynin concentration (ng/mL) over 24 hours after administration of Oxybutynin 5 mg TID (three times daily). The x-axis represents time in hours, and the y-axis shows concentration with error bars indicating variability. Peaks occur approximately every 8 hours, correlating with dosing intervals.*

FDA Label Image

Figure2 (Figure2)

A line graph showing mean plasma R-oxybutynin concentration (ng/mL) over time (hours). The x-axis represents time from 0 to 12 hours, and the y-axis represents concentration from 0 to 10 ng/mL. Data points indicate a peak concentration around 1 hour followed by a gradual decline to near baseline at 12 hours, with error bars representing variability at each time point.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.